Nonpeptide endothelin antagonists in clinical development

被引：22
|
作者：
Wu, CD [1 ]
Decker, ER [1 ]
Holland, GW [1 ]
Brown, PM [1 ]
Stavros, FD [1 ]
Brock, TA [1 ]
Dixon, RAF [1 ]
机构：
[1] Texas Biotechnol Corp, Houston, TX 77030 USA
来源：
DRUGS OF TODAY | 2001年 / 37卷 / 07期
关键词：
D O I：
10.1358/dot.2001.37.7.844187
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：441 / 453
页数：13
相关论文
共 50 条
  • [31] Nonpeptide vitronectin receptor antagonists
    Keenan, R
    Miller, W
    Ali, F
    Barton, L
    Bondinell, B
    Burgess, J
    Callahan, J
    Calvo, R
    Cousins, R
    Gowen, M
    Huffman, W
    Hwang, S
    Jakas, D
    Ku, T
    Kwon, C
    Lago, A
    Mombouyran, V
    Nguyen, T
    Ross, S
    Samanen, J
    Takata, D
    Uzinskas, I
    Venslavsky, J
    Wong, A
    Yellin, T
    Yuan, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 236 - MEDI
  • [32] Nonpeptide vitronectin receptor antagonists
    Miller, W
    Keenan, R
    Ali, F
    Bondinell, W
    Burgess, J
    Callahan, J
    Calvo, R
    Cousins, R
    Gowen, M
    Huffman, W
    Hwang, S
    Jakas, D
    Ku, T
    Kwon, C
    Lago, A
    Nguyen, T
    Reader, V
    Ross, S
    Samanen, J
    Southall, L
    Takata, D
    Uzinskas, I
    Venslavsky, J
    Wong, A
    Yellin, T
    Yuan, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M429 - M429
  • [33] 1,3-DIARYLINDAN-2-CARBOXYLIC ACIDS, POTENT AND SELECTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTS
    ELLIOTT, JD
    LAGO, MA
    COUSINS, RD
    GAO, AM
    LEBER, JD
    ERHARD, KF
    NAMBI, P
    ELSHOURBAGY, NA
    KUMAR, C
    LEE, JA
    BEAN, JW
    DEBROSSE, CW
    EGGLESTON, DS
    BROOKS, DP
    FEUERSTEIN, G
    RUFFOLO, RR
    WEINSTOCK, J
    GLEASON, JG
    PEISHOFF, CE
    OHLSTEIN, EH
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (11) : 1553 - 1557
  • [34] Nonpeptide antagonists for kinin receptors
    Altamura, R
    Meini, S
    Quartara, L
    Maggi, CA
    REGULATORY PEPTIDES, 1999, 80 (1-2) : 13 - 26
  • [35] Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: Effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors
    Willette, RN
    Sauermelch, CF
    Storer, BL
    Guiney, S
    Luengo, JI
    Xiang, JN
    Elliott, JD
    Ohlstein, EH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S149 - S157
  • [36] Nonpeptide endothelin receptor antagonists.: XI.: Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist
    Ohlstein, EH
    Nambi, P
    Hay, DWP
    Gellai, M
    Brooks, DP
    Luengo, J
    Xiang, JN
    Elliott, JD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (02): : 650 - 656
  • [37] Endothelin and endothelin antagonists in hypertension
    Schiffrin, EL
    JOURNAL OF HYPERTENSION, 1998, 16 : S32 - S32
  • [38] Endothelin and endothelin antagonists in hypertension
    Schiffrin, EL
    JOURNAL OF HYPERTENSION, 1998, 16 (12) : 1891 - 1895
  • [39] Endothelin receptor antagonists - Clinical realities and future directions
    Kirchengast, M
    Luz, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 45 (02) : 182 - 191
  • [40] The clinical potential of endothelin receptor antagonists in cardiovascular medicine
    Ferro, CJ
    Webb, DJ
    DRUGS, 1996, 51 (01) : 12 - 27
12345